Trazodone, a phenylpiperazine–triazolopyridine antidepressant, was originally discovered and developed in Italy in the 1970s by Angelini research laboratories. Trazodone is used to treat depression and to treat the combination of symptoms of anxiety and depression. Like most antidepressants, trazodone has also been used in limited numbers of patients to treat panic disorder, obsessive-compulsive disorder, attention-deficit/hyperactivity disorder, enuresis (bed-wetting), eating disorders such as bulimia nervosa, cocaine dependency, and the depressive phase of bipolar (manic-depressive) disorder. It should be noted, however, that trazodone has not received official approval from the United States Food and Drug Administration (FDA) for these secondary uses.
Only few manufacturers can produce trazodone hydrochloride (API) in USA. Teva, the Israeli company, has a production base in the United States, dominates the market with the production market share of 92.98% in 2015
The price of trazodone hydrochloride (API) has a overall upward trend from 2011 to 2016, with a little decrease in 2012 and 2015. The average price of trazodone hydrochloride (API) is about 218 USD/Kg in 2015. The average product profit margin is about 55.82% in 2015, and it also experienced fluctuations in recent years.
Global Trazodone Hydrochloride (API) market size will increase to xx Million US$ by 2025, from xx Million US$ in 2018, at a CAGR of xx% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Trazodone Hydrochloride (API).
This report researches the worldwide Trazodone Hydrochloride (API) market size (value, capacity, production and consumption) in key regions like United States, Europe, Asia Pacific (China, Japan) and other regions.
This study categorizes the global Trazodone Hydrochloride (API) breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
The following manufacturers are covered in this report:
Teva
Angelini
Mylan
Fermion
The Piramal Group
Trazodone Hydrochloride (API) Breakdown Data by Type
Trazodone Hydrochloride (API)
Others
Trazodone Hydrochloride (API) Breakdown Data by Application
Antidepression
Anxiolytic
Hypnotic
Others
Trazodone Hydrochloride (API) Production Breakdown Data by Region
United States
Europe
China
Japan
Other Regions
Trazodone Hydrochloride (API) Consumption Breakdown Data by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Rest of Europe
Central & South America
Brazil
Rest of South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
Rest of Middle East & Africa
The study objectives are:
To analyze and research the global Trazodone Hydrochloride (API) capacity, production, value, consumption, status and forecast;
To focus on the key Trazodone Hydrochloride (API) manufacturers and study the capacity, production, value, market share and development plans in next few years.
To focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Trazodone Hydrochloride (API) :
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Summary:
Get latest Market Research Reports on Trazodone Hydrochloride (API) . Industry analysis & Market Report on Trazodone Hydrochloride (API) is a syndicated market report, published as Global Trazodone Hydrochloride (API) Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Trazodone Hydrochloride (API) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.